ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 135 filers reported holding ARGENX SE in Q3 2019. The put-call ratio across all filers is 0.80 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $812,590 | -85.7% | 2,145 | -86.6% | 0.02% | -87.1% |
| Q3 2022 | $5,666,000 | +157.2% | 16,048 | +119.3% | 0.18% | +137.3% |
| Q2 2021 | $2,203,000 | +457.7% | 7,317 | +409.9% | 0.08% | +240.9% |
| Q1 2021 | $395,000 | -93.7% | 1,435 | -94.9% | 0.02% | -95.1% |
| Q2 2020 | $6,295,000 | +56.2% | 27,949 | +11.3% | 0.45% | +45.3% |
| Q4 2019 | $4,031,000 | +36.4% | 25,114 | -3.2% | 0.31% | -15.5% |
| Q3 2019 | $2,956,000 | +503.3% | 25,938 | +561.0% | 0.37% | +348.8% |
| Q1 2019 | $490,000 | – | 3,924 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |